Transition Bio last raised $13.3M in its Early Stage VC (Oct 2024).
- ·Watch Transition Bio: the Monday email on marks, rounds and moves
Transition Bio funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2024 | Early Stage VC | $13.3M | ▮ | ▮ |
| Dec 2023 | Early Stage VC | $6.0M | ▮ | ▮ |
| Mar 2022 | Early Stage VC | $39.1M | ▮ | ▮ |
Membership and data by Private Market View
Transition Bio valuation
Transition Bio's last known valuation is $26.8 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Transition Bio raised?
Transition Bio has raised $76.5 million across 3 recorded rounds since 2022. The largest was a $6 million early-stage round in Dec 2023; the most recent was a $13.3 million early-stage round in Oct 2024.
Transition Bio has filed 4 Form Ds with the SEC since 2022, most recently in Oct 2024 ($13.3 million sold to 8 investors).
How Transition Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Transition Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Transition Bio
- What is Transition Bio worth?
- Transition Bio's last known valuation is $26.8M.
- How much has Transition Bio raised?
- Transition Bio has raised $76.5M in total funding across 3 recorded rounds.
- When did Transition Bio last raise?
- Transition Bio last raised in Oct 2024 (Early Stage VC), raising $13.3M.